CurePharma L.L.C. is the pioneer in the manufacture of antineoplastic products in the Syrian market and the Arab World.
We manufacture three dosage forms of antineoplastic products including injectable sterile solutions, lyophilized powders, and solid tablets in a site of total built area of 10.000 m2 on four floors. The plant had been constructed by Syrian specialists with sophisticated machineries from world class companies.
Our company is located in the food and drug zone in Adra industrial city, 40 km north of Damascus, Syria with total Capital of 30 Million Euros.
CurePharma achieved a steady and consistent progress to become one of the pioneering innovative forces in the local market.
We, with the expertise of our prominent pharmaceutical experts, work to step ahead towards a strong economy in our country away from import business with locally manufactured antineoplastic high-quality products that comply with the highest international standards.